Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

Melatonin helps regulate hair growth and may treat hair loss.

Finasteride, a hair loss drug, can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

PDGF signaling may play a role in hair growth cycle regulation.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Transferrin receptor expression increases iron in mouse skin cells without causing damage.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

TRPV4 channel affects skin health and could be a target for treating skin disorders.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.